Your browser doesn't support javascript.
loading
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Saji, Shigehira; Taira, Naruto; Kitada, Masahiro; Takano, Toshimi; Takada, Masahiro; Ohtake, Tohru; Toyama, Tatsuya; Kikawa, Yuichiro; Hasegawa, Yoshie; Fujisawa, Tomomi; Kashiwaba, Masahiro; Ishida, Takanori; Nakamura, Rikiya; Yamamoto, Yutaka; Toh, Uhi; Iwata, Hiroji; Masuda, Norikazu; Morita, Satoshi; Ohno, Shinji; Toi, Masakazu.
Afiliación
  • Saji S; Department of Medical Oncology, Fukushima Medical University Hospital, Fukushima, Japan. Electronic address: ss-saji@wa2.so-net.ne.jp.
  • Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
  • Kitada M; Breast Disease Center, Asahikawa Medical University Hospital, Hokkaido, Japan.
  • Takano T; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
  • Takada M; Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ohtake T; Department of Breast Surgery, Fukushima Medical University Hospital, Fukushima, Japan.
  • Toyama T; Department of Breast Surgery, Nagoya University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kikawa Y; Department of Breast Surgery, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Hasegawa Y; Department of Breast Surgery, Hachinohe City Hospital, Aomori, Japan.
  • Fujisawa T; Department of Breast Oncology, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Kashiwaba M; Department of Breast Surgery, Adachi Breast Clinic, Kyoto, Japan.
  • Ishida T; Department of Breast and Endocrine Surgical Oncology, Tohoku University Hospital, Miyagi, Japan.
  • Nakamura R; Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Yamamoto Y; Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Toh U; Department of Breast Surgery, Kurume University Hospital, Fukuoka, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Masuda N; Department of Breast and Endocrine Surgery, Nagoya City University Graduate School of Medicine, Nagoya, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ohno S; Breast Oncology Center, Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Toi M; Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Lancet Oncol ; 23(5): 636-649, 2022 05.
Article en En | MEDLINE | ID: mdl-35405087
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article